Growing T cells in the lab for clinical use
About the project:
Gamma delta T cells are specialized immune cells that attack and kill cells within the body that have been infected by bacteria or a viruses, and cells that are showing indications of turning cancerous.
Unlike other T cells, Gamma delta T cells do not need to be immunologically matched to the cells that they target, which means that they could be made in the lab at scale for transplant into any patient with appropriate indications. However, currently, making these cells in large numbers is difficult, constraining their potential wider adoption as a therapuetic option.
Lead researcher: Professor Ed Stanley
Investigators: Professor Dan Pellicci, A/ Professor Elizabeth Ng and Professor Andrew Elefanty
Tissue of interest: Immune system
Proudly in partnership with
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729